Castle Biosciences Inc’s recently made public that its Chief Operating Officer Oelschlager Kristen M unloaded Company’s shares for reported $0.28 million on Aug 27 ’25. In the deal valued at $22.02 per share,12,677 shares were sold. As a result of this transaction, Oelschlager Kristen M now holds 141,116 shares worth roughly $3.39 million.
Then, Oelschlager Kristen M sold 18,007 shares, generating $390,572 in total proceeds. Upon selling the shares at $21.69, the Chief Operating Officer now owns 153,793 shares.
Before that, Kristen M. Oelschlager bought 18,007 shares. Castle Biosciences Inc shares valued at $384,449 were divested by the Officer at a price of $21.35 per share.
Guggenheim initiated its Castle Biosciences Inc [CSTL] rating to a Buy in a research note published on December 14, 2023; the price target was $25. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Stephens began covering CSTL with “an Overweight” recommendation on January 07, 2022. Lake Street started covering the stock on April 30, 2021. It rated CSTL as “a Buy”.
Price Performance Review of CSTL
On Friday, Castle Biosciences Inc [NASDAQ:CSTL] saw its stock jump 2.34% to $24.01. Over the last five days, the stock has gained 15.21%. Castle Biosciences Inc shares have fallen nearly -18.44% since the year began. Nevertheless, the stocks have fallen -9.91% over the past one year. While a 52-week high of $35.84 was reached on 01/08/25, a 52-week low of $14.59 was recorded on 08/04/25.
Levels Of Support And Resistance For CSTL Stock
The 24-hour chart illustrates a support level at 23.29, which if violated will result in even more drops to 22.58. On the upside, there is a resistance level at 24.38. A further resistance level may holdings at 24.76.
How much short interest is there in Castle Biosciences Inc?
A steep rise in short interest was recorded in Castle Biosciences Inc stocks on 2025-08-15, dropping by -0.12 million shares to a total of 1.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 1.41 million shares. There was a decline of -9.63%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
